All of these findings confirm the fact that NEAT1 is upregulated in the fibrosis of NASH patients compared to controls and underlines the potential value of NEAT1 in NASH diagnosis and prognosis [118]. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatohepatitis.